Articles Vol. 67 No. 6 25/06/2026

CASE REPORT OF IDIOPATHIC RETROPERITONEAL PELVIC SARCOMA INVADING THE SIGMOID MESOCOLON, OVARY, AND FALLOPIAN TUBE

Nguyen Hong Hai1,2,3, Luu Thi Bich Ngoc1,2,3, Nguyen Viet Thu1,2,3,4, Hoang Van Lan Duc1,2,3,4, Vu Huy Hoang2,3,4,5, Hoang Thi Kim Khuyen2,3,4,5, Le Anh Viet2,3,4,5
1 Center for Diagnostic Imaging and Interventional Radiology, Vinmec Times City International General Hospital, Vinmec Healthcare System, Hanoi, Vietnam
2 College of Health Sciences, VinUniversity, Hanoi, Vietnam
3 Trung tâm chẩn đoán hình ảnh và điện quang can thiệp, Bệnh viện Đa khoa quốc tế Vinmec Times city, Vinmec Healthcare System, Hà Nội, Việt Nam.
4 College of Health Sciences, VinUniversity, Hanoi, Vietnam.
5 Center for Diagnostic Imaging and Interventional Radiology, Vinmec Times City International General Hospital, Vinmec Healthcare System, Hanoi, Vietnam.
DOI: 10.52163/yhc.v67i6.5493
27 Views
11 Downloads
Abstract

 

Retroperitoneal pelvic sarcoma is a rare malignant condition that often presents with nonspecific clinical manifestations and can be easily misdiagnosed as gynecological or gastrointestinal tumors. Preoperative diagnosis is challenging due to the paucity of symptoms and atypical imaging features. We report a case of idiopathic retroperitoneal pelvic sarcoma invading the sigmoid mesocolon, ovary, and fallopian tube in a 57-year-old female patient. The patient was evaluated using advanced imaging modalities and treated with wide surgical excision of the tumor together with the involved structures, achieving negative surgical margins. Histopathological examination confirmed the diagnosis of sarcoma, with features consistent with leiomyosarcoma. The treatment course highlights the pivotal role of radical surgical resection in achieving favorable outcomes. This case adds valuable data to the existing literature and underscores the importance of differential diagnosis and a multidisciplinary approach in the management of rare pelvic tumors.

References
[1]
Schmitz E, Nessim C. Retroperitoneal Sarcoma Care in 2021. Cancers. 2022 Mar 2;14(5):1293. DOI: 10.3390/cancers14051293. Google Scholar
[2]
Shiraev T, Pasricha SS, Choong P, Schlicht S, van Rijswijk CS, Dimmick S, et al. Retroperitoneal sarcomas: a review of disease spectrum, radiological features, characterisation and management. J Med Imaging Radiat Oncol. 2013 Dec;57(6):687–700. DOI: 10.1111/1754-9485.12123. Google Scholar
[3]
Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. Ann R Coll Surg Engl. 2011 May;93(4):275–80. DOI: 10.1308/003588411X571944. Google Scholar
[4]
Ferrario T, Karakousis CP. Retroperitoneal Sarcomas: Grade and Survival. Arch Surg. 2003 Mar 1;138(3):248–51. DOI: 10.1001/archsurg.138.3.248. Google Scholar
[5]
Lu C, Zhang L, Xu B, Li T, Fan D, Li C, et al. A case report of retroperitoneal leiomyosarcoma originating from the right ovarian vein and invading the right renal vein and inferior vena cava. J Int Med Res. 2025 Aug;53(8):3000605251364059. DOI: 10.1177/03000605251364059. Google Scholar
[6]
Lee JS, Kelly CM, Bartlett EK. Management of pelvic sarcoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2022 Nov;48(11):2299–307. DOI: 10.1016/j.ejso.2022.09.011. Google Scholar
[7]
Mousa AH, Nukaly HY, Ahmed RA, Zubair TM, Merdad MJ, Rahman M, et al. An accidental finding of a retroperitoneal desmoid tumor: case report and review of the literature. Ann Med Surg. 2023 Feb;85(2):246–51. DOI: 10.1097/MS9.0000000000000205. Google Scholar